Loading…
Loading…
As noted last week, midstream MLPs and corporations broadly raised full-year financial guidance following a strong second quarter. Looking ahead, the sector's growth runway is accelerating.
Wall Street analysts are reshuffling their bets ahead of a critical inflation report and NVIDIA earnings that could jolt markets in either direction. Find out which names got upgraded, cut, or newly covered before the opening bell Wednesday.
Investors need to pay close attention to DTM stock based on the movements in the options market lately.
DT Midstream commands a premium valuation due to its shift from gathering to pipeline-focused natural gas infrastructure with dual demand engines: LNG/industrial and utility/data center end markets. DTM's $3.4 billion brownfield project backlog, with 5x–8x build multiples, underpins visible EBITDA growth and justifies the premium versus sector peers trading at lower multiples. Robust dividend coverage (2.3x–2.5x), investment-grade leverage (2.9x–3.5x), and long-term firm contracts (95% of 2025 revenues) support balance sheet strength and cash flow stability.
West Pharmaceuticals stock moved higher following another quarter of broad-based growth, driven by continued demand for high-value biologics packaging and proprietary delivery components. Tyler Technologies underperformed during the quarter despite delivering solid financial results that met management's guidance. We were attracted to Knowles' accelerating organic growth, expanding margins, and exposure to several attractive long-term secular trends.
DT Midstream NYSE: DTM said it reached final investment decisions on approximately $300 million of new organic growth projects during the second quarter, advancing expansions across its Haynesville, Midwest and Appalachian operations as natural-gas demand from LNG exports, power generation and data centers continues to support development activity.
DT Midstream, Inc. (DTM) Q2 2026 Earnings Call Transcript
DETROIT, July 30, 2026 (GLOBE NEWSWIRE) -- DT Midstream, Inc. (NYSE: DTM) today announced second quarter 2026 reported net income of $112 million, or $1.09 per diluted share and Operating Earnings of $112 million, or $1.09 per diluted share. Adjusted EBITDA for the quarter was $305 million.